Literature DB >> 12183290

Bone marrow transplants.

Peter W M Johnson, Kim Orchard.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12183290      PMCID: PMC1123870          DOI: 10.1136/bmj.325.7360.348

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?

Authors:  S MacKinnon
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

2.  Overview of the six available randomized trials of high-dose chemotherapy with blood or marrow transplant in breast cancer.

Authors:  K H Antman
Journal:  J Natl Cancer Inst Monogr       Date:  2001

Review 3.  Novel approaches to transplant conditioning.

Authors:  B J Hennessy; K H Orchard; M N Potter
Journal:  Hematol Oncol       Date:  2001-06       Impact factor: 5.271

Review 4.  Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma.

Authors:  A Fassas; G Tricot
Journal:  Semin Hematol       Date:  2001-07       Impact factor: 3.851

Review 5.  Haematopoietic cell transplantation as immunotherapy.

Authors:  F R Appelbaum
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 6.  Bone marrow and peripheral blood stem cell transplantation for malignancy.

Authors:  P W Johnson; S J Simnett; J W Sweetenham; G J Morgan; L A Stewart
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

7.  High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.

Authors:  A M Gianni; M Bregni; S Siena; C Brambilla; M Di Nicola; F Lombardi; L Gandola; C Tarella; A Pileri; F Ravagnani; P Valagussa; G Bonadonna
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

Review 8.  Nonmyeloablative stem cell transplantation for solid tumors: expanding the application of allogeneic immunotherapy.

Authors:  Richard Childs; John Barrett
Journal:  Semin Hematol       Date:  2002-01       Impact factor: 3.851

9.  Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.

Authors:  M Magni; M Di Nicola; L Devizzi; P Matteucci; F Lombardi; L Gandola; F Ravagnani; R Giardini; G Dastoli; C Tarella; A Pileri; G Bonadonna; A M Gianni
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

10.  Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  A K Burnett; A H Goldstone; R M Stevens; I M Hann; J K Rees; R G Gray; K Wheatley
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.